Danish DanCann Pharma was founded in 2018 by its present CEO, Jeppe Krog Rasmussen. That was right after the Danish cannabis pilot programme was entered into force. The business idea is to utilize on the beneficial circumstances in Denmark to serve the European market with high quality medical cannabis products, prescription based or over the counter (OTC).
| Homepage: | www.dancann.com |
| Initial Coverage: | April 23, 2021 |
| Sector: | Healthcare |
| Exchange: | Spotlight |
| Ticker: | DANCAN:SS |
2022-06-09: Research update DanCann Pharma, Q1 2022: Building pipeline ahead of launch
2022-03-24: Research update DanCann Pharma Q4 2021: The start of a new era?
2021-12-07: Research update, Q3 2021: Brighter outlook than ever before
2021-10-12: Research update, Q2 2021: Transformative acquisition adds great value
2021-06-03 Research update, Q1 2021: Good news flow increases fair value
2021-05-26 Mrkt Buzz: Pilot programme extended = good news
2021-05-05 Mrkt BUZZ: Important deal with Tetra finalized
